Description

Clinical relapse rates and disease activity indices are compared between the AID and CFG groups, assessing whether dietary intervention prevents flares in ulcerative colitis patients.

Figure 4

Chart

Source Paper

Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission.

Nutrients (2022)

PMID: 36014800

DOI: 10.3390/nu14163294

Cite This Figure

![Figure 4: Clinical relapse rates and disease activity indices are compared between the AID and CFG groups, assessing whether dietary intervention prevents flares in ulcerative colitis patients.]()

> Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." *Nutrients*, 2022. PMID: [36014800](https://pubmed.ncbi.nlm.nih.gov/36014800/)

<figure>
  <img src="" alt="Clinical relapse rates and disease activity indices are compared between the AID and CFG groups, assessing whether dietary intervention prevents flares in ulcerative colitis patients." />
  <figcaption>Figure 4. Clinical relapse rates and disease activity indices are compared between the AID and CFG groups, assessing whether dietary intervention prevents flares in ulcerative colitis patients.<br>  Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014800/">36014800</a></figcaption>
</figure>

Related Evidence

Omega-3 Fatty Acids (EPA/DHA) for Ulcerative Colitis (UC)

Grade C · 8 studies